Japanese Encephalitis

Total Page:16

File Type:pdf, Size:1020Kb

Japanese Encephalitis J Neurol Neurosurg Psychiatry 2000;68:405–415 405 NEUROLOGICAL ASPECTS OF TROPICAL DISEASE Japanese encephalitis Tom Solomon, Nguyen Minh Dung, Rachel Kneen, Mary Gainsborough, David W Vaughn, Vo Thi Khanh Although considered by many in the west to be West Nile virus, a flavivirus found in Africa, the a rare and exotic infection, Japanese encephali- Middle East, and parts of Europe, is tradition- tis is numerically one of the most important ally associated with a syndrome of fever causes of viral encephalitis worldwide, with an arthralgia and rash, and with occasional estimated 50 000 cases and 15 000 deaths nervous system disease. However, in 1996 West annually.12About one third of patients die, and Nile virus caused an outbreak of encephalitis in half of the survivors have severe neuropshychi- Romania,5 and a West Nile-like flavivirus was atric sequelae. Most of China, Southeast Asia, responsible for an encephalitis outbreak in and the Indian subcontinent are aVected by the New York in 1999.67 virus, which is spreading at an alarming rate. In In northern Europe and northern Asia, flavi- these areas, wards full of children and young viruses have evolved to use ticks as vectors adults aZicted by Japanese encephalitis attest because they are more abundant than mosqui- Department of to its importance. toes in cooler climates. Far eastern tick-borne Neurological Science, University of encephalitis virus (also known as Russian Liverpool, Walton Historical perspective spring-summer encephalitis virus) is endemic Centre for Neurology Epidemics of encephalitis were described in in the eastern part of the former USSR, and and Neurosurgery, Japan from the 1870s onwards. Major epidem- Western tick-borne encephalitis virus occurs in Fazakerley, Liverpool ics were reported about every 10 years, with Europe and has caused recent epidemics in L9 7LJ, UK Germany and Austria.8 In the United Kingdom Tom Solomon more than 6000 cases reported in the 1924 epidemic.3 The term type B encephalitis was the tick borne Louping Ill virus is is enzootic in Liverpool School of originally used to distinguish these summer sheep, and occasionally causes encephalitis in 9 Tropical Medicine, epidemics from von Economo’s encephalitis sheep and humans. Pembroke Place, lethargica (sleeping sickness, known as type A), Liverpool L3 5QA, UK but the B has since been dropped. In 1933 a ENZOOTIC CYCLE Tom Solomon filterable agent was transmitted from the brain Japanese encephalitis virus is transmitted natu- Centre for Tropical of a fatal case to cause encephalitis in monkeys; rally between wild and domestic birds, and pigs Diseases, Cho Quan the prototype Nakayama strain of Japanese by Culex mosquitoes—the most important for Hospital, Ho Chi Minh encephalitis virus was isolated from the brain of human infection being Culex tritaeniorrhynchus City, Vietnam a fatal case in 1935. The virus was later classed which breeds in pools of stagnant water (such Nguyen Minh Dung as a member of the genus Flavivirus (family as rice paddy fields).10 Although many animals Mary Gainsborough Vo Thi Khanh Flaviviridae) named after the prototype yellow can be infected with the virus, only those which fever virus (Latin; yellow=flavi). Although of develop high viraemias are important in the Royal Liverpool no taxonomic significance, the ecological term natural cycle. As well as maintaining and Children’s NHS Trust, arbovirus is often used to describe the fact that amplifying Japanese encephalitis virus in the Alder Hey, Liverpool Japanese encephalitis virus is insect (arthro- environment, birds may also be responsible for L12 2AP,UK pod) borne. the spread to new geographical areas. Pigs are Rachel Kneen the most important natural host for transmis- Centre for Tropical Epidemiology sion to humans, because they are often kept Medicine and NEUROTROPIC FLAVIVIRUSES: A GLOBAL close to humans, have prolonged and high Infectious Diseases, PERSPECTIVE viraemias, and produce many oVspring—thus NuYeld Department Japanese encephalitis virus is transmitted providing a continuous supply of previously of Clinical Medicine, uninfected new hosts. The virus does not typi- John RadcliVe between animals by Culex mosquitoes, and Hospital, Headington, occurs across eastern and southern Asia and cally cause encephalitis in these natural hosts, Oxford, OX3 9DU, UK the Pacific rim. However, related neurotropic athough abortions occur in pregnant sows. Mary Gainsborough flaviviruses are found across the globe (fig 1); they share many virological, epidemiological, EPIDEMIOLOGY OF HUMAN DISEASE Department of Virus and clinical features.2 Molecular virological Humans become infected with Japanese en- Diseases, Walter Reed Army Institute of studies suggest that all flaviviruses derived cephalitis virus coincidentally when living or Research, Washington, from a common ancestor some 10–20 000 travelling in close proximity to the enzootic DC 20307, USA years ago, and are rapidly evolving to fill cycle of the virus. Although most cases occur in David W Vaughn ecological niches.4 Examples of mosquito rural areas, Japanese encephalitis virus is also borne neurotropic flaviviruses include Murray found on the edge of cities. Epidemiological Correspondence to: Dr Tom Solomon Valley encephalitis virus in Australia, and St studies have shown that after the monsoon [email protected] Louis encephalitis virus in North America. rains mosquitoes breed prolifically, and as their 406 Solomon, Dung, Kneen, et al Figure 1 Map showing approximate global distribution of major neurotropic flaviviruses; JE=Japanese encephalitis; MVE=Murray valley encephalitis; WN=West Nile; WTBE=Western tick-borne encephalitis; FETBE=Far Eastern tick-borne encephalitis; LI=Louping Ill virus; SLE=St Louis encephalitis. numbers grow, so does their carriage of are also aVected.20 The susceptibility of immu- Japanese encephalitis virus and the infection nologically naive adults was also demonstrated rate of pigs.11 12 Human infection soon follows. by the incidence of Japanese encephalitis In sentinel studies, previously unexposed pigs among American troops during conflicts in placed in endemic areas were infected with the Japan, Korea, and Vietnam21–25 The rate of virus within weeks. symptomatic infection was higher in these Although the virus has occasionally been troops than in local populations. This may be isolated from human peripheral blood13 virae- explained by partial protection due to previous mias are usually brief and titres low; thus flavivirus exposure in the indigenous popula- humans are considered a dead end host from tion, age related diVerences, diVerent genetic which transmission does not normally occur. susceptibility to Japanese encephalitis, or more Cross sectional serological surveys have shown sensitive disease surveillance among United that in rural Asia most of the population are States troops. infected with Japanese encephalitis virus dur- Broadly speaking two epidemiological pat- ing childhood or early adulthood.14 About 10% terns of Japanese encephalitis are recognised.19 of the susceptible population is infected each In northern areas (northern Vietnam, northern year.15 However, most infections of humans are Thailand, Korea, Japan, Taiwan, China, Nepal, asymptomatic or result in a non-specific and northern India) huge epidemics occur flu-like illness; estimates of the ratio of sympto- during the summer months, whereas in south- matic to asymptomatic infection vary between ern areas (southern Vietnam, southern Thai- 1in2516 and 1 in 1000.17 land, Indonesia, Malaysia, Philippines, Sri Japanese encephalitis is mostly a disease of Lanka, and southern India) Japanese encepha- children and young adults. In northern Thai- litis tends to be endemic, and cases occur spo- land the incidence has been estimated to be up radically throughout the year with a peak after to 40 per 100 000 for ages 5 to 25, declining to the start of the rainy season.19 almost zero for those over 3514 18 The incidence Various explanations for this diVerent pat- is lower among young children (<3 years old) tern have been oVered. The finding that than in older children, possibly reflecting Japanese encephalitis virus isolates from epi- behavioural factors—for example, playing out- demic northern Thailand and endemic south- side after dusk.19 ern Thailand were of diVerent genotypes (see When epidemics first occur in new locations, below) led to the suggestion that diVering neu- such as in Sri Lanka, India, and Nepal, adults rovirulence among diVerent strains may be Japanese encephalitis 407 25 remains high through the year, the number of A cases each month is constant. In the north a sharp rise in cases of Japanese encephalitis 20 during the summer months corresponds with a rise in temperature above 20°C. The prolonged mosquito larval development time and longer 15 extrinsic incubation period of Japanese en- cephalitis virus at cooler temperature, which % thus reduce the rate of virus transmission, 10 could be one explanation for these findings. GEOGRAPHICAL DISTRIBUTION 5 In the past 50 years the geographical area aVected by Japanese encephalitis virus has expanded (fig 1). DiVerences in diagnostic capabilities and in reporting of encephalitis 0 make it impossible to plot this expansion precisely. However, the timing of the first 35 B reported cases or new epidemics in each area gives an impression of the relentless spread of 30 Japanese encephalitis. In China outbreaks of summer encephalitis occurred from 1935, and 25 the virus was first isolated there in 1940; there are currently 10–20 000 cases a year, although 20 in the early 1970s it was over 80 000 cases annually.19 In the far eastern Russian states, C ° Japanese encephalitis first occurred in 1938. In 15 1949, large epidemics were reported from South Korea for the first time. Epidemics in 10 Hanoi northern Vietnam followed in 1965 (currently Ho Chi Minh City 1000–3000 cases nationally a year), and in 5 Chiang Mai in northern Thailand in 1969 (currently 1500–2500 cases nationally a year). 0 Japanese encephalitis was recognised in south- ern India from 1955, but was confined to the south until the 1970s. Since then, large 400 C outbreaks (2000–7000 cases a year) have been 350 reported from eastern and northeastern states.
Recommended publications
  • Zika Virus Outside Africa Edward B
    Zika Virus Outside Africa Edward B. Hayes Zika virus (ZIKV) is a flavivirus related to yellow fever, est (4). Serologic studies indicated that humans could also dengue, West Nile, and Japanese encephalitis viruses. In be infected (5). Transmission of ZIKV by artificially fed 2007 ZIKV caused an outbreak of relatively mild disease Ae. aegypti mosquitoes to mice and a monkey in a labora- characterized by rash, arthralgia, and conjunctivitis on Yap tory was reported in 1956 (6). Island in the southwestern Pacific Ocean. This was the first ZIKV was isolated from humans in Nigeria during time that ZIKV was detected outside of Africa and Asia. The studies conducted in 1968 and during 1971–1975; in 1 history, transmission dynamics, virology, and clinical mani- festations of ZIKV disease are discussed, along with the study, 40% of the persons tested had neutralizing antibody possibility for diagnostic confusion between ZIKV illness to ZIKV (7–9). Human isolates were obtained from febrile and dengue. The emergence of ZIKV outside of its previ- children 10 months, 2 years (2 cases), and 3 years of age, ously known geographic range should prompt awareness of all without other clinical details described, and from a 10 the potential for ZIKV to spread to other Pacific islands and year-old boy with fever, headache, and body pains (7,8). the Americas. From 1951 through 1981, serologic evidence of human ZIKV infection was reported from other African coun- tries such as Uganda, Tanzania, Egypt, Central African n April 2007, an outbreak of illness characterized by rash, Republic, Sierra Leone (10), and Gabon, and in parts of arthralgia, and conjunctivitis was reported on Yap Island I Asia including India, Malaysia, the Philippines, Thailand, in the Federated States of Micronesia.
    [Show full text]
  • A Replication-Defective Japanese Encephalitis Virus (JEV)
    www.nature.com/npjvaccines ARTICLE OPEN A replication-defective Japanese encephalitis virus (JEV) vaccine candidate with NS1 deletion confers dual protection against JEV and West Nile virus in mice ✉ Na Li1,2, Zhe-Rui Zhang1,2, Ya-Nan Zhang1,2, Jing Liu1,2, Cheng-Lin Deng1, Pei-Yong Shi3, Zhi-Ming Yuan1, Han-Qing Ye 1 and ✉ Bo Zhang 1,4 In our previous study, we have demonstrated in the context of WNV-ΔNS1 vaccine (a replication-defective West Nile virus (WNV) lacking NS1) that the NS1 trans-complementation system may offer a promising platform for the development of safe and efficient flavivirus vaccines only requiring one dose. Here, we produced high titer (107 IU/ml) replication-defective Japanese encephalitis virus (JEV) with NS1 deletion (JEV-ΔNS1) in the BHK-21 cell line stably expressing NS1 (BHKNS1) using the same strategy. JEV-ΔNS1 appeared safe with a remarkable genetic stability and high degrees of attenuation of in vivo neuroinvasiveness and neurovirulence. Meanwhile, it was demonstrated to be highly immunogenic in mice after a single dose, providing similar degrees of protection to SA14-14-2 vaccine (a most widely used live attenuated JEV vaccine), with healthy condition, undetectable viremia and gradually rising body weight. Importantly, we also found JEV-ΔNS1 induced robust cross-protective immune responses against the challenge of heterologous West Nile virus (WNV), another important member in the same JEV serocomplex, accounting for up to 80% survival rate following a single dose of immunization relative to mock-vaccinated mice. These results not only support the identification of 1234567890():,; the NS1-deleted flavivirus vaccines with a satisfied balance between safety and efficacy, but also demonstrate the potential of the JEV-ΔNS1 as an alternative vaccine candidate against both JEV and WNV challenge.
    [Show full text]
  • Clinically Important Vector-Borne Diseases of Europe
    Natalie Cleton, DVM Erasmus MC, Rotterdam Department of Viroscience [email protected] No potential conflicts of interest to disclose © by author ESCMID Online Lecture Library Erasmus Medical Centre Department of Viroscience Laboratory Diagnosis of Arboviruses © by author Natalie Cleton ESCMID Online LectureMarion Library Koopmans Chantal Reusken [email protected] Distribution Arboviruses with public health impact have a global and ever changing distribution © by author ESCMID Online Lecture Library Notifications of vector-borne diseases in the last 6 months on Healthmap.org Syndromes of arboviral diseases 1) Febrile syndrome: – Fever & Malaise – Headache & retro-orbital pain – Myalgia 2) Neurological syndrome: – Meningitis, encephalitis & myelitis – Convulsions & coma – Paralysis 3) Hemorrhagic syndrome: – Low platelet count, liver enlargement – Petechiae © by author – Spontaneous or persistent bleeding – Shock 4) Arthralgia,ESCMID Arthritis and Online Rash: Lecture Library – Exanthema or maculopapular rash – Polyarthralgia & polyarthritis Human arboviruses: 4 main virus families Family Genus Species examples Flaviviridae flavivirus Dengue 1-5 (DENV) West Nile virus (WNV) Yellow fever virus (YFV) Zika virus (ZIKV) Tick-borne encephalitis virus (TBEV) Togaviridae alphavirus Chikungunya virus (CHIKV) O’Nyong Nyong virus (ONNV) Mayaro virus (MAYV) Sindbis virus (SINV) Ross River virus (RRV) Barmah forest virus (BFV) Bunyaviridae nairo-, phlebo-©, orthobunyavirus by authorCrimean -Congo heamoragic fever (CCHFV) Sandfly fever virus
    [Show full text]
  • Virulence of Japanese Encephalitis Virus Genotypes I and III, Taiwan
    Virulence of Japanese Encephalitis Virus Genotypes I and III, Taiwan Yi-Chin Fan,1 Jen-Wei Lin,1 Shu-Ying Liao, within a year (8,9), which provided an excellent opportu- Jo-Mei Chen, Yi-Ying Chen, Hsien-Chung Chiu, nity to study the transmission dynamics and pathogenicity Chen-Chang Shih, Chi-Ming Chen, of these 2 JEV genotypes. Ruey-Yi Chang, Chwan-Chuen King, A mouse model showed that the pathogenic potential Wei-June Chen, Yi-Ting Ko, Chao-Chin Chang, is similar among different JEV genotypes (10). However, Shyan-Song Chiou the pathogenic difference between GI and GIII virus infec- tions among humans remains unclear. Endy et al. report- The virulence of genotype I (GI) Japanese encephalitis vi- ed that the proportion of asymptomatic infected persons rus (JEV) is under debate. We investigated differences in among total infected persons (asymptomatic ratio) is an the virulence of GI and GIII JEV by calculating asymptomat- excellent indicator for estimating virulence or pathogenic- ic ratios based on serologic studies during GI- and GIII-JEV endemic periods. The results suggested equal virulence of ity of dengue virus infections among humans (11). We used GI and GIII JEV among humans. the asymptomatic ratio method for a study to determine if GI JEV is associated with lower virulence than GIII JEV among humans in Taiwan. apanese encephalitis virus (JEV), a mosquitoborne Jflavivirus, causes Japanese encephalitis (JE). This virus The Study has been reported in Southeast Asia and Western Pacific re- JEVs were identified in 6 locations in Taiwan during 1994– gions since it emerged during the 1870s in Japan (1).
    [Show full text]
  • Hantavirus Infection Is Inhibited by Griffithsin in Cell Culture
    BRIEF RESEARCH REPORT published: 04 November 2020 doi: 10.3389/fcimb.2020.561502 Hantavirus Infection Is Inhibited by Griffithsin in Cell Culture Punya Shrivastava-Ranjan 1, Michael K. Lo 1, Payel Chatterjee 1, Mike Flint 1, Stuart T. Nichol 1, Joel M. Montgomery 1, Barry R. O’Keefe 2,3 and Christina F. Spiropoulou 1* 1 Division of High Consequence Pathogens and Pathology, Viral Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, GA, United States, 2 Molecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, United States, 3 Division of Cancer Treatment and Diagnosis, Natural Products Branch, Developmental Therapeutics Program, National Cancer Institute, Frederick, MD, United States Andes virus (ANDV) and Sin Nombre virus (SNV), highly pathogenic hantaviruses, cause hantavirus pulmonary syndrome in the Americas. Currently no therapeutics are approved for use against these infections. Griffithsin (GRFT) is a high-mannose oligosaccharide-binding lectin currently being evaluated in phase I clinical trials as a topical microbicide for the prevention of human immunodeficiency virus (HIV-1) infection (ClinicalTrials.gov Identifiers: NCT04032717, NCT02875119) and has shown Edited by: broad-spectrum in vivo activity against other viruses, including severe acute respiratory Alemka Markotic, syndrome coronavirus, hepatitis C virus, Japanese encephalitis virus, and Nipah virus. University Hospital for Infectious Diseases “Dr. Fran Mihaljevic,” Croatia In this study, we evaluated the in vitro antiviral activity of GRFT and its synthetic trimeric Reviewed by: tandemer 3mGRFT against ANDV and SNV. Our results demonstrate that GRFT is a Zhilong Yang, potent inhibitor of ANDV infection. GRFT inhibited entry of pseudo-particles typed with Kansas State University, United States ANDV envelope glycoprotein into host cells, suggesting that it inhibits viral envelope Gill Diamond, University of Louisville, United States protein function during entry.
    [Show full text]
  • Inactivated Japanese Encephalitis Virus Vaccine
    January 8, 1993 / Vol. 42 / No. RR-1 CENTERS FOR DISEASE CONTROL AND PREVENTION Recommendations and Reports Inactivated Japanese Encephalitis Virus Vaccine Recommendations of the Advisory Committee on Immunization Practices (ACIP) U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Centers for Disease Control and Prevention (CDC) Atlanta, Georgia 30333 The MMWR series of publications is published by the Epidemiology Program Office, Centers for Disease Control and Prevention (CDC), Public Health Service, U.S. Depart- ment of Health and Human Services, Atlanta, Georgia 30333. SUGGESTED CITATION Centers for Disease Control and Prevention. Inactivated Japanese encephalitis vi- rus vaccine. Recommendations of the advisory committee on immunization practices (ACIP). MMWR 1993;42(No. RR-1):[inclusive page numbers]. Centers for Disease Control and Prevention .................... William L. Roper, M.D., M.P.H. Director The material in this report was prepared for publication by: National Center for Infectious Diseases..................................James M. Hughes, M.D. Director Division of Vector-Borne Infectious Diseases ........................Duane J. Gubler, Sc.D. Director The production of this report as an MMWR serial publication was coordinated in: Epidemiology Program Office.................................... Stephen B. Thacker, M.D., M.Sc. Director Richard A. Goodman, M.D., M.P.H. Editor, MMWR Series Scientific Information and Communications Program Recommendations and Reports ................................... Suzanne M. Hewitt, M.P.A. Managing Editor Sharon D. Hoskins Project Editor Rachel J. Wilson Editorial Trainee Peter M. Jenkins Visual Information Specialist Use of trade names is for identification only and does not imply endorsement by the Public Health Service or the U.S. Department of Health and Human Services.
    [Show full text]
  • Competency of Amphibians and Reptiles and Their Potential Role As Reservoir Hosts for Rift Valley Fever Virus
    viruses Article Competency of Amphibians and Reptiles and Their Potential Role as Reservoir Hosts for Rift Valley Fever Virus Melanie Rissmann 1, Nils Kley 1, Reiner Ulrich 2,3 , Franziska Stoek 1, Anne Balkema-Buschmann 1 , Martin Eiden 1 and Martin H. Groschup 1,* 1 Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, 17493 Greifswald-Insel Riems, Germany; melanie.rissmann@fli.de (M.R.); [email protected] (N.K.); franziska.stoek@fli.de (F.S.); anne.balkema-buschmann@fli.de (A.B.-B.); martin.eiden@fli.de (M.E.) 2 Department of Experimental Animal Facilities and Biorisk Management, Friedrich-Loeffler-Institut, 17493 Greifswald-Insel Riems, Germany; [email protected] 3 Institute of Veterinary Pathology, Leipzig University, 04103 Leipzig, Germany * Correspondence: martin.groschup@fli.de; Tel.: +49-38351-7-1163 Received: 10 September 2020; Accepted: 19 October 2020; Published: 23 October 2020 Abstract: Rift Valley fever phlebovirus (RVFV) is an arthropod-borne zoonotic pathogen, which is endemic in Africa, causing large epidemics, characterized by severe diseases in ruminants but also in humans. As in vitro and field investigations proposed amphibians and reptiles to potentially play a role in the enzootic amplification of the virus, we experimentally infected African common toads and common agamas with two RVFV strains. Lymph or sera, as well as oral, cutaneous and anal swabs were collected from the challenged animals to investigate seroconversion, viremia and virus shedding. Furthermore, groups of animals were euthanized 3, 10 and 21 days post-infection (dpi) to examine viral loads in different tissues during the infection. Our data show for the first time that toads are refractory to RVFV infection, showing neither seroconversion, viremia, shedding nor tissue manifestation.
    [Show full text]
  • Preparedness and Response for Chikungunya Virus: Introduction in the Americas Washington, D.C.: PAHO, © 2011
    O P S N N O PR O V United States of America Washington, D.C. 20037, 525 Twenty-third Street, N.W., I S M A U L U N T D E I O H P A PAHO/CDC PREparEDNESS AND RESPONSE FOR CHIKUNGUNYA VIRUS INTRODUCTION IN THE AMERICAS Chikungunya Virus Chikungunya Introduction in theAmericas in Introduction Preparedness andResponse for Preparedness and Response for Chikungunya Virus Introduction in the Americas S A LU O T R E P O P A P H S O N I O D V I M U N PAHO HQ Library Cataloguing-in-Publication Pan American Health Organization Preparedness and Response for Chikungunya Virus: Introduction in the Americas Washington, D.C.: PAHO, © 2011 ISBN: 978-92-75-11632-6 I. Title 1. VECTOR CONTROL 2. COMMUNICABLE DISEASE CONTROL 3. EPIDEMIOLOGIC SURVEILLANCE 4. DISEASE OUTBREAKS 5. VIRUS DISEASE - transmission 6. LABORATORY TECHNIQUES AND PROCEDURES 7. AMERICAS NLM QX 650.DA1 The Pan American Health Organization welcomes requests for permission to reproduce or translate its publications, in part or in full. Applications and inquiries should be addressed to Editorial Services, Area of Knowledge Management and Communications (KMC), Pan American Health Organization, Washington, D.C., U.S.A. The Area for Health Surveillance and Disease Prevention and Control, Project for Alert and Response and Epidemic Diseases, at (202) 974-3010 or via email at [email protected], will be glad to provide the latest information on any changes made to the text, plans for new editions, and reprints and translations already available. ©Pan American Health Organization, 2011.
    [Show full text]
  • Speaker Notes
    Japanese Encephalitis S Japanese encephalitis is a mosquito-borne viral infection of horses, pigs l and humans. It is also referred to as Japanese B encephalitis, arbovirus B, i and mosquito-borne encephalitis virus. d Japanese Encephalitis e Japanese B Encephalitis, Arbovirus B 1 S In today’s presentation we will cover information regarding the organism l Overview that causes Japanese encephalitis and the epidemiology of the disease. We i • Economic Impact will also talk about the economic impact the disease has had in the past • Epidemiology and could have in the future. Additionally, we will talk about how it is d • Transmission transmitted, the species it affects, the clinical signs and necropsy findings, e • Clinical Signs as well as the diagnosis and treatment of the disease. Finally, we will • Diagnosis and Treatment • Disease in Humans address prevention and control measures for the disease as well as actions 2 • Prevention and Control to take if Japanese encephalitis is suspected. • Actions to Take Center for Food Security and Public Health, Iowa State University, 2011 (Photo of Culex mosquito laying eggs, from CDC website at www.cdc.gov/ncidod/dvbid/jencphalitis) S l i d The Organism e 3 S Japanese Encephalitis (JE) virus belongs to the genus Flavivirus in the l Japanese Encephalitis family Flaviviridae (related to St. Louis encephalitis virus, Murray valley i • Genus Flavivirus virus, and West Nile virus). The name of the family is derived from the • Name derived from Latin ‘flavus’ meaning yellow, which refers to the yellow fever virus, d the Latin flavus meaning also a member of this family.
    [Show full text]
  • Japanese Encephalitis
    Alberta Health Public Health Disease Management Guidelines Japanese Encephalitis Revision Dates Case Definition March 2011 Reporting Requirements May 2018 Remainder of the Guideline (i.e., Etiology to References sections inclusive) March 2011 Case Definition Confirmed Case Clinical illness(A) with laboratory confirmation of infection: Isolation of japanese encephalitis virus (JE) from an appropriate clinical specimen OR Detection of JE viral nucleic acid (e.g., PCR) in an appropriate clinical specimen OR Seroconversion or significant difference between acute and convalescent phase JE HAI titres ideally taken at least 2 weeks apart and confirmed by PRNT(B,C). Probable Case Clinical illness(A) and one of the following: Seroconversion or significant difference between acute and convalescent phase JE HAI titres ideally taken at least 2 weeks apart but not confirmed by PRNT(B) OR Stable elevated serial HAI titres(D) to JE that occur during a period when and where arboviral transmission is likely(E) OR Single elevated HAI titre(D) to JE that occurs during a period when and where arboviral transmission is likely(E). (A) Clinical illness is characterized by a febrile illness of variable severity associated with neurological symptoms ranging from headache to aseptic meningitis or encephalitis. Arboviral encephalitis cannot be distinguished clinically from other central nervous system (CNS) infections. Symptoms can include headache, confusion or other alteration in sensorium, nausea and vomiting. Signs may include fever, meningismus, cranial nerve palsies, paresis or paralysis, sensory deficits, altered reflexes, convulsions, abnormal movements and coma of varying degree. (B) Seroconversion indicates recent infection with a flavivirus (e.g., dengue fever, California serogroup, West Nile virus or yellow fever) but cannot pinpoint which one due to antibody cross-reactivity.
    [Show full text]
  • Japanese Encephalitis Virus Complex Mediated Amplification Assay (Procleix, Novartis)
    Japanese Encephalitis Virus Complex mediated amplification assay (Procleix, Novartis). The same patient was negative when tested with the Cobas Taqscreen Disease Agent: (Roche) WNV PCR assay. • Japanese encephalitis virus (JEV) and Usutu virus Common Human Exposure Routes: (USUV) • Vector-borne (Culex mosquitoes) Disease Agent Characteristics: Likelihood of Secondary Transmission: • Family: Flaviviridae; Genus: Flavivirus • Virion morphology and size: Enveloped, icosahedral nucleo- • For JEV, absent except for rare intrauterine transmission capsid symmetry, spherical particles, 40 to 60 nm in recorded diameter • Undocumented for USUV • Nucleic acid: Linear, positive-sense, single-stranded RNA At-Risk Populations: genome, ~11.0 kb in length • Physicochemical properties: Infectivity inactivated and • Widely distributed in Asia destroyed by heating for 10 minutes at >56°C; half life of 7 • Affects all ages, but especially children and the elderly hours at 37°C; sensitive to treatment with lipid solvents, Vector and Reservoir Involved: detergents, ether, trypsin, chloroform, formaldehyde, heat and b-propiolactone; infectivity reduced after exposure to • Main epidemic JEV vectors are mosquitoes of the Culex irradiation and inactivated at pH 1-3 species, especially C. tritaeniorhynchus, which is an evening- and nighttime-biting mosquito that feeds preferentially on Disease Name: pigs and birds and infrequently on humans. Culicine mos- • Japanese encephalitis quitos are also the vectors for USUV. • In temperate regions, pigs and birds (principally ardeid Priority Level: species, such as egrets and black-crowned night herons, and • Scientific/Epidemiologic evidence regarding blood safety: possibly ducks) are effective amplifying hosts for JEV. USUV Theoretical; because of the similarity to West Nile virus circulates in birds. (WNV), transfusion risk during JEV outbreaks may occur.
    [Show full text]
  • Point-Of-Care Diagnostics for Dengue, Chikungunya, Japanese Encephalitis and West Nile Virus Infection
    Short note Point-of-care diagnostics for dengue, chikungunya, Japanese encephalitis and West Nile virus infection Subhash C. Arya and Nirmala Agarwal Sant Parmanand Hospital, 18 Alipore Road, Delhi-110054 The global resurgence of dengue in otherwise sample was positive for two infections, viz. JEV naive locations has been associated with and West Nile virus (WNV).[6] concurrent dissemination of identical vector- borne viral diseases. Concurrent infection by There has been no chemotherapy available dengue virus (DENV) and chikungunya virus for patients with JEV, DENV, CHIKV or WNV. (CHIKV) has been known for several Such cases require appropriate clinical decades.[1] Nevertheless, recent global CHIKV management and public health response. During dissemination[2] or its local re-emergence[3] after the initial stage of illness the clinical presentations a gap has been intriguing. Increased are ambiguous and are accompanied by viremia. intercontinental travel has blown up the ghost These cases are highly infectious with their blood of the traditional endemic foci of CHIKV and teeming with viral RNA. If bitten by the mosquito has resulted in CHIKV patients being found in vector, they would contribute to disease the United States.[4] Moreover, there could dissemination. Moreover, they are likely to be even be coincidental episodes of the Japanese offered empirical doses of antibiotics by the encephalitis virus (JEV) infection. During the clinicians. Any point-of-care indication about JEV, early 1940s, there were dengue outbreaks in DENV, CHIKV or WNV would be imperative Guam, followed, during 1947, by the from the clinical and public health perspective. concurrent epidemics of mumps virus and JEV.
    [Show full text]